case_images: PMC8194346_01
case_images: Patient exhibited pseudoprogression of pulmonary lesions after 2 months of treatment with nivolumab plus CIK cell transfer and achieved a partial remission after 4 months.
case_images: fonc-11-640447-g001.jpg
case_images: PMC8194346_01_fonc-11-640447-g001.jpg
case_images: f1
case_images: After 6 months of therapy, a CT showed that the lesions in the lungs had begun to decrease ( Figure 1 ).
case_images: MRI during treatment with nivolumab and CIK cells. MRI revealed two enhancing metastatic lesions within the brain parenchyma 6 months after the initiation of treatment. The brain lesions disappeared after 6 months of continued treatment.
case_images: fonc-11-640447-g002.jpg
case_images: PMC8194346_01_fonc-11-640447-g002.jpg
case_images: f2
case_images: After an additional 5 months (May 2019), symptoms disappeared, and another enhanced MRI found the brain lesions had disappeared ( Figure 2 ).
case_images: Timeline of the patient treatment.
case_images: fonc-11-640447-g003.jpg
case_images: PMC8194346_01_fonc-11-640447-g003.jpg
case_images: f3
case_images: The timeline of the patient's disease development, treatment and outcome is shown in  Figure 3 .